Evidence map›Paper›PMID 35579444›Full record

ArticleMicrobiology spectrum2022

Development of Resistance to Clarithromycin and Amoxicillin-Clavulanic Acid in

V V Kostenko, A A Mouzykantov, N B Baranova, E A Boulygina, M I Markelova, D R Khusnutdinova, M V Trushin, O A Chernova, V M Chernov

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Repression ofMicroorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

V V KostenkoLaboratory of Molecular Bases of Pathogenesis, Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, Kazan, Russia.
A A MouzykantovLaboratory of Molecular Bases of Pathogenesis, Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, Kazan, Russia.
N B BaranovaLaboratory of Molecular Bases of Pathogenesis, Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, Kazan, Russia.
E A BoulyginaInstitute of Fundamental Medicine and Biology, Kazan Federal Universitygrid.77268.3c, Kazan, Russia.ORCID 0000-0003-3458-1176
M I MarkelovaLaboratory of Molecular Bases of Pathogenesis, Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, Kazan, Russia.
D R KhusnutdinovaInstitute of Fundamental Medicine and Biology, Kazan Federal Universitygrid.77268.3c, Kazan, Russia.
M V TrushinInstitute of Fundamental Medicine and Biology, Kazan Federal Universitygrid.77268.3c, Kazan, Russia.ORCID 0000-0001-7467-011X
O A ChernovaLaboratory of Molecular Bases of Pathogenesis, Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, Kazan, Russia.
V M ChernovLaboratory of Molecular Bases of Pathogenesis, Kazan Institute of Biochemistry and Biophysics, Russian Academy of Sciences, Kazan, Russia.
Kazan Institute of Biochemistry and Biophysics · RUKazan Federal University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ensuring the safety of the use of probiotics is a top priority. Obviously, in addition to studying the beneficial properties of lactic acid bacteria, considerable attention should be directed to assessing the virulence of microorganisms as well as investigating the possibility of its evolution under conditions of selective pressure. To assess the virulence of probiotics, it is now recommended to analyze the genomes of bacteria in relation to the profiles of the virulome, resistome, and mobilome as well as the analysis of phenotypic resistance and virulence

Indexed as

ClarithromycinProbioticsAmoxicillin-Potassium Clavulanate CombinationAnimalsAnti-Bacterial AgentsDrosophila melanogasterGenomicsLactobacillaceaeVirulenceAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsClarithromycinantibiotic resistanceDrosophila melanogastergenomic rearrangementsLactiplantibacillus plantarummobilomephenotypic resistanceprobioticsresistomevirulencevirulome

Identifiers

PMID35579444
PMCPMC9241834
OpenAlexW4280528510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.